Decrease in long-term disability: New drug for stroke patients

Seeking long-term disability benefits can be long and arduous road. Access to medical innovation is responsible for keeping large numbers of United States. residents off long-term disability who would have otherwise joined them. Recent reports in Wisconsin reveal that a new drug therapy method reduces functional disability and the need for long-term disability benefits.

Doctors across the country are coming around to a once-controversial drug therapy used to stop strokes and put an end to debilitating brain damage. The drug, named Alteplase (or Activase), has proved to make impressive results for patients that are responsive to the drug. Studies show that nearly 40 percent of stroke patients see results and have made noteworthy recoveries.

There is still a large risk for the drug, misuse of the drug can cause brain hemorrhages, although doctors are finally getting the hang of utilizing the drug with appropriate patients. Patients who qualify and show the best results are those brought to the hospital within a two-hour window of the initial stroke symptoms. Amongst other qualifications, patients can be candidates for the drug if they experience a blot clot-induced stroke in the cerebral artery, rather than the common stroke suffered when bleeding in the brain occurs.

Although a risk still stands to be taken, doctors are more confident utilizing the blood clot-reducing drug today, decreasing long-term damage for stroke patients. In turn, long-term disability benefits are not necessary for as many stroke victims, and the recovery process is much smoother. Long-term disability benefits may still be accessible for those who are in need no matter the medical condition. Wisconsin residents may find relief by seeking legal guidance to stand up for your rights with regard to long-term disability benefits.

Source:, More Stroke Patients Now Get Clot-Busting Drug, Richard Knox Enlarge, Aug. 28, 2013


FindLaw Network